MET and head and neck squamous cell carcinoma: Effect of the EGFR Polymorphism R521K on the In Vitro Sensitivity of HNSCC Cell Lines to the EGFR Specific Therapeutic Antibody Cetuximab, and Small-Molecule Inhibitors of EGFR, RAS, and c-MET